Taking into account that the inhibition of AChE has been one of the most used strategies for treating AD and that existing drugs are effective only against mild to moderate type of disease while presenting considerable side effects, the search for new sources of effective and selective antiacetylcholinesterase agents with fewer side effects is imperative. Here, ACHE is linked to Alzheimer disease.